[ad_1] Johnson & Johnson has reached tentative agreement to resolve talc baby powder claims with more than 40 states, the world’s biggest maker of health care...
[ad_1] A New Jersey court has tossed a nearly $224 million verdict against Johnson & Johnson that was awarded to four people who alleged in a...
[ad_1] U.S. stocks finished mostly lower Thursday, with the Nasdaq and S&P 500 dragged down by disappointing earnings, while the Dow Jones Industrial Average rose for...
[ad_1] IPO investors, much like retail shoppers in recent years’ inflationary environment, are demanding clear discounts and demonstrating sensitivity to price and valuations, according to Renaissance...
[ad_1] Eli Lilly & Co.’s market cap neared Johnson & Johnson’s market cap on Friday, as the stock has benefited from a slew of positive data...
[ad_1] Kenvue Inc. shares KVUE, +18.86% were cheered in their Wall Street debut Thursday, as the Johnson & Johnson JNJ, -0.24% spinoff, with consumer brands including...
[ad_1] A unit of Johnson & Johnson is headed for the biggest initial public offering in more than a year after its shares were priced near...
[ad_1] Johnson & Johnson said Tuesday that it will offer at least $8.9 billion to resolve thousands of lawsuits filed by people alleging that the company’s...
[ad_1] Johnson & Johnson JNJ, +1.05% stock rose nearly 3% in the extended session Tuesday after the company said it was setting aside $8.9 billion to...
[ad_1] A few days into the first Lunar New Year holiday since the lifting of pandemic restrictions in China, Chinese consumers are eager to travel but...
[ad_1] The Food and Drug Administration is recommending that the U.S. decide each June which SARS-CoV-2 strains should be included in an annual fall booster shot....
[ad_1] It has taken just one day for Tesla Inc.’s stock to erase the entire bounce it enjoyed over the last three days trading sessions of...
[ad_1] Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare autoimmune diseases, in a deal valued at $26.4 billion. Each Horizon...
[ad_1] The Centers for Disease Control and Prevention has refuted claims that it’s planning to add the COVID-19 vaccine to immunization schedules for schoolchildren, saying that...